Adaptive Biotechnologies Corp. (ADPT)
25.55
-0.44
(-1.69%)
USD |
NASDAQ |
Aug 24, 16:00
25.51
-0.04
(-0.16%)
After-Hours: 07:02
Adaptive Biotechnologies 1 Year Total Returns (Daily) : 96.54% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 96.54% |
| August 21, 2026 | 105.8% |
| August 20, 2026 | 106.9% |
| August 19, 2026 | 102.9% |
| August 18, 2026 | 97.90% |
| August 17, 2026 | 89.95% |
| August 14, 2026 | 91.49% |
| August 13, 2026 | 88.15% |
| August 12, 2026 | 99.45% |
| August 11, 2026 | 109.0% |
| August 10, 2026 | 108.6% |
| August 07, 2026 | 98.80% |
| August 06, 2026 | 101.9% |
| August 05, 2026 | 122.6% |
| August 04, 2026 | 125.0% |
| August 03, 2026 | 123.7% |
| July 31, 2026 | 120.4% |
| July 30, 2026 | 131.6% |
| July 29, 2026 | 117.1% |
| July 28, 2026 | 112.3% |
| July 27, 2026 | 109.7% |
| July 24, 2026 | 108.9% |
| July 23, 2026 | 105.2% |
| July 22, 2026 | 108.5% |
| July 21, 2026 | 119.0% |
| Date | Value |
|---|---|
| July 20, 2026 | 110.4% |
| July 17, 2026 | 118.3% |
| July 16, 2026 | 104.1% |
| July 15, 2026 | 107.1% |
| July 14, 2026 | 85.54% |
| July 13, 2026 | 77.83% |
| July 10, 2026 | 74.34% |
| July 09, 2026 | 82.73% |
| July 08, 2026 | 71.72% |
| July 07, 2026 | 77.34% |
| July 06, 2026 | 82.20% |
| July 02, 2026 | 84.58% |
| July 01, 2026 | 99.91% |
| June 30, 2026 | 84.12% |
| June 29, 2026 | 81.51% |
| June 26, 2026 | 72.37% |
| June 25, 2026 | 69.03% |
| June 24, 2026 | 81.60% |
| June 23, 2026 | 63.16% |
| June 22, 2026 | 67.34% |
| June 18, 2026 | 67.43% |
| June 17, 2026 | 65.48% |
| June 16, 2026 | 67.35% |
| June 15, 2026 | 69.19% |
| June 12, 2026 | 69.07% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Personalis, Inc. | 253.2% |
| 10X Genomics, Inc. | 346.2% |
| Alamar Biosciences, Inc. (California) | -- |
| Champions Oncology, Inc. | -34.86% |
| Medpace Holdings, Inc. | 33.73% |